Back to EveryPatent.com
United States Patent | 5,216,130 |
Line ,   et al. | June 1, 1993 |
To localize targets within the body (i.e., fixed intravascular antigens on emboli, neovascular endothelium, endothelium altered by regional inflammation) antibodies are linked via dextran spacer arms to rapidly cleared, Tc-99m labeled, microspheres. A micron-sized, albumin microsphere has been synthesized that is designed to enhance target surface interaction and to have a high antibody loading capacity. Stable, hydrophilic microspheres are produced from a pH dependent refolding of albumin followed by heat annealing. To couple dextran, the microspheres are derivatized with succinic anhydride and then linked via carbodiimide to succinic dihydrazide. After periodate oxidized dextran forms hydrazone linkages to the microspheres, additional dihydrazide coupled to the dextran spacer arm is used to link periodate oxidized IgG via its Fc domain carbohydrate. A milligram of the resulting 0.5-1.0 micron microspheres contains 50 to 350 ug of dextran and up to 10.sup.5 covalently bound IgG molecules per microsphere. Microspheres exposed to SnCl.sub.2 can be labeled with 90 Mci/mg of Tc-99m. Spheres with high levels of dextran SDH clear the blood rapidly (T.sub.1/2 =2.6-4 min) compared to those coated with native dextran (T.sub.1/2 =35-50 min). These labelled albumin targeting microspheres may be used to detect a variety of sites of clinical interest using non-invasive external imaging devices and may be employed to carry therapeutic agents to these sites.
Inventors: | Line; Bruce R. (Delmar, NY); Weber; Peter B. (Delmar, NY) |
Assignee: | Albany Medical College (Albany, NY) |
Appl. No.: | 525258 |
Filed: | May 17, 1990 |
Current U.S. Class: | 530/362; 424/1.37; 424/1.53; 424/179.1; 424/450; 530/363; 530/391.1; 530/391.3; 530/391.5; 530/391.7; 530/391.9; 530/409; 536/51; 536/112 |
Intern'l Class: | C07K 017/10; C07K 015/14; A61K 039/44; A61K 047/48 |
Field of Search: | 530/362,363,384,409,391.1,391.3,391.5,391.7,391.9 514/21,59 536/51,112 424/1.1,85.91,450 |
4138383 | Feb., 1979 | Rembaum et al. | 524/809. |
4224198 | Sep., 1980 | Rembaum et al. | 525/54. |
4413070 | Nov., 1983 | Rembaum | 523/223. |
4452773 | Jun., 1984 | Molday | 424/1. |
4622322 | Nov., 1986 | Rembaum | 525/54. |
4671954 | Jun., 1987 | Goldberg et al. | 424/450. |
4678814 | Jul., 1987 | Rembaum | 522/175. |
4710525 | Dec., 1987 | Kraemer et al. | 523/201. |
4762915 | Aug., 1988 | Kung et al. | 530/405. |
4829101 | May., 1989 | Kraemer et al. | 523/201. |
4861597 | Aug., 1989 | Kida et al. | 424/450. |
4867973 | Sep., 1989 | Goers et al. | 424/85. |
Foreign Patent Documents | |||
0087786 | Sep., 1983 | EP. | |
0357401 | Mar., 1990 | EP. | |
8807365 | Oct., 1988 | WO. |
Blair et al. (1983) J. Immunol. Methods 59:129-143. Yan et al. (1988) Biotech Appl. Biochem 10(1):13-20. Scheffel et al. (1972) J. Nucl. Med. 13: 498-503. P. K. Gupta and C. T. Hung, Life Sciences 44:175-186 (1989). E. Fattal et al., Antimicro Agents and Chemotherapy 33:1540-1543 (1989). V. J. Wiebe and M. W. DeGregorio, Rev. of Infect Dis 10:1097-1101 (1988). D. Liu and L. Huang, Biochim Biophys Acta 1022:348-354 (1990). C.-Y. Wang and L. Huang, Biochemistry 28:9508-9514 (1989). B. J. Hughes et al., Cancer Res 49:6214-6220 (1989). J. Leibovici et al., Int J Immunopharmac 11:133-147 (1989). S. K. Lo et al., J. Immunology 143:3325-3329 (1989). D. A. A. Vignali et al., J. Immunology 144:4030-4037 (1990). K. B. Hymes et al., Blood 75:1813-1819 (1990). K. H. Singer et al., J. Immunology 144:2931-2939 (1990). T. F. Tedder et al., J Immunology 144:532-540 (1990). O. W. Blaschuk et al., Developmental Biology 139:227-229 (1990). T. Nitta et al., J. Exp Med 170:1757-1761 (1989). Morrison and Boyd, Organic Chemistry, 3d Edition, Allyn and Bacon, Inc., Boston, Mass. (1977). Dorland's Illustrated Medical Dictionary, 26th Edition. W. B. Saunders Co., Philadelphia, Pa. (1981). W. Pigman, Ed., The Carbohydrates, Academic Press Inc., New York, N.Y. (1957). Hoffman, W. L. and O'Shannessy, D. J., Journal of Immunological Methods 112: 113-120 (1988). Wilson, M. R. and Wotherspoon, J. S., Journal of Immunological Methods 107: 225-230 (1988). Fujiwara, K., et al., Journal of Immunological Methods, 110: 47-53 (1988). Schwarz, J. A. et al., Int'l. J. of Clinical Pharmacology 19(8): 358-367 (1981). Rhodes, B. A., et al., J. Nuclear Medicine 27: 685-693 (1986). Knight, L. C., et al., J. Nuclear Medicine 29: 494-502 (1988). L. C. Knight, Seminar in Nuclear Medicine, vol. 20: (Jan. 1990), pp. 52-67. Illum, L. and Jones, D. E., Methods of Enzymology 112: 67-84 (1983). Gershoni, J. M., et al., Analytical Biochemistry 146: 59-63 (1983). Molteni, L., Methods of Enzymology 112: 285-298 (1985). Ghose, D. A., Methods in Enzymology, 93: 280-333 (1983). Burger, J. J., et al. Methods in Enzymology, 112: 43-56 (1985). Line, B., et al., Abstract #16363, The Society of Nuclear Medicine, 36th Annual Meeting, St. Louis, Mo., Jun. 13, 1989-Jun. 16, 1989. |